Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Start treatment early and give it for long enough
| The first 150 words of the full text of this article appear below. |
With the advent of an unlimited supply of
recombinant DNA growth hormone some 15 years ago endocrinologists and
paediatricians hoped that the major goal in treating children with
growth hormone deficiency
that is, a near normal adult height
would
finally be achievable.
Carel and colleagues report in this issue the adult height after
"long term" recombinant growth hormone treatment for idiopathic isolated growth hormone deficiency.1 The investigators
were able to analyse entry data on all French children with growth hormone deficiency whose treatment started between 1987 and 1992 and
stopped in 1996 under the auspices of the French national programme,
Association France Hypophyse. They then were able to record adult
heights for 76% of these patients. Gain in height was on average a
disappointing 1.1 (0.9 SD). Overall, the treatment of a child for about
three years (certainly not "long term") was associated with an
estimated gain in height of only 4.2 cm. Faced with these
Read all Rapid Responses